Cargando…

High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar

Protease-Activated Receptor-1 (PAR1) is the prototypical member of a family of G protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the N-terminal exodomain of the receptor, which exposes a tethered peptide li...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Srinivasan, Yoga, Arlow, Daniel H., Fung, Juan Jose, Palmer, Daniel, Zheng, Yaowu, Green, Hillary F., Pandey, Anjali, Dror, Ron O., Shaw, David E., Weis, William I., Coughlin, Shaun R., Kobilka, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531875/
https://www.ncbi.nlm.nih.gov/pubmed/23222541
http://dx.doi.org/10.1038/nature11701
Descripción
Sumario:Protease-Activated Receptor-1 (PAR1) is the prototypical member of a family of G protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the N-terminal exodomain of the receptor, which exposes a tethered peptide ligand that binds the receptor’s heptahelical bundle to effect G protein-activation. Here we report a 2.2Å resolution crystal structure of human PAR1 bound to vorapaxar, a PAR1 antagonist. The structure reveals an unusual mode of drug binding that explains how a small molecule binds virtually irreversibly to inhibit receptor activation by PAR1’s tethered ligand. In contrast to deep, solvent-exposed binding pockets observed in other peptide-activated GPCRs, the vorapaxar-binding pocket is superficial but has little surface exposed to the aqueous solvent. PARs are important targets for drug development. The structure reported here will aid development of improved PAR1 antagonists and discovery of antagonists to other members of this receptor family.